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SUMMARY
eIF4E, the major cap-binding protein, has long been considered limiting for translating the mammalian genome. However, the eIF4E dose requirement at an organismal level remains unexplored. By generating an Eif4e haploinsufficient mouse, we found that a 50% reduction in eIF4E expression, while compatible with normal development and global protein synthesis, significantly impeded cellular transformation. Genome-wide translational profiling uncovered a translational program induced by oncogenic transformation and revealed a critical role for the dose of eIF4E, specifically in translating a network of mRNAs enriched for a unique 5 0 UTR signature. In particular, we demonstrate that the dose of eIF4E is essential for translating mRNAs that regulate reactive oxygen species, fueling transformation and cancer cell survival in vivo. Our findings indicate eIF4E is maintained at levels in excess for normal development that are hijacked by cancer cells to drive a translational program supporting tumorigenesis.
INTRODUCTION
For decades, the major cap binding protein eukaryotic initiation factor 4E (eIF4E) has been recognized as the quantitatively limiting initiation factor for mRNA translation (Duncan et al., 1987; Hiremath et al., 1985) . eIF4E is a critical component of the eIF4F tertiary translation initiation complex, which recognizes the 5 0 7-methyl guanosine cap of mRNAs and drives their translation. In addition to eIF4E, the eIF4F complex is comprised of the DEAD-box helicase eIF4A and eIF4G, a large protein scaffold that recruits the 40S ribosome subunit to mature mRNAs (Gingras et al., 1999) . As the limiting component of the eIF4F complex, eIF4E expression levels are believed to be critical determinants in translation of eukaryotic mRNAs (De Benedetti et al., 1991) . In particular, the translation of mRNAs harboring structured 5
0 UTRs is thought to be exquisitely sensitive to eIF4E levels due to eIF4E's ability to both recruit the eIF4A helicase to the 5 0 cap and stimulate its activity in a cap-independent manner (Feoktistova et al., 2013) . Collectively, even small changes in eIF4E levels are believed to broadly impact mRNA translation and thus cellular and organismal function ( Figure 1A) . However, the normal physiological role and threshold for the dose of eIF4E in organismal development in vivo is essentially unknown. Moreover, the specific eIF4E dose requirements for both global and specific translation of mRNAs genome-wide remain poorly defined.
In this study, we generate a mouse model for Eif4e haploinsufficiency as a genetic tool to define Eif4e dose requirements in vivo. Surprisingly, we find that eIF4E exists in excess for normal development and global protein synthesis and instead becomes limiting under the specific condition of oncogeneinduced cellular transformation. Employing unbiased genomewide profiling to identify the translational landscape of mRNAs induced by oncogenic transformation, we delineate an ''oncogenic translation program'' comprised of hundreds of mRNAs. Several key nodes in this program, including functional classes of mRNAs, such as those involved in signaling and control of reactive oxygen species (ROS), are exquisitely sensitive to the dose of eIF4E.
One of the defining stress phenotypes that cancer cells encounter is the buildup of ROS, and cancer cells typically generate more ROS than do normal cells (Szatrowski and Nathan, 1991) . The ability of cancer cells to distinguish between ROS as a survival or apoptotic signal is controlled by the dosage and duration of ROS production, such that modest levels are required for cancer cell survival, whereas excessive levels promote cell death (Trachootham et al., 2006; Weinberg et al., 2010) . Here, we show that the capacity to properly translate mRNAs regulating intracellular ROS levels is critical for tumor cell survival. Indeed, we demonstrate that reductions in eIF4E cause a toxic accumulation of ROS rendering, at least in part, a remarkable resistance to transformation in Eif4e haploinsufficient mice. These studies thereby reveal a mechanism by which cancer cells regulate the translation of key stress response transcripts in a manner that is directly coupled to the dose of eIF4E in the cell. Collectively, these findings highlight that mammalian cells have evolved a surplus of eIF4E that exists above the required threshold for normal development and physiology and instead plays a specialized role in regulating mRNA translation under specific conditions, which has been co-opted by tumor cells to weather the stress of oncogenic transformation.
RESULTS

In Vivo Requirements for an eIF4E Threshold
In order to address the in vivo requirements for an eIF4E threshold, we generated an Eif4e knockout mouse (Figures S1A and S1B). We reasoned that in the context of Eif4e heterozygosity (Eif4e +/À ), the impact of a 50% reduction in the level of eIF4E could be assessed genetically at the organismal level to delineate the in vivo function of eIF4E dose. Surprisingly, Eif4e +/À mice are viable and indistinguishable from their WT littermates. For example, Eif4e
mice are born at normal Mendelian ratios (Table S1 ) and display normal body weight ( Figure S1C ) and survival (data not shown) Table S1 .
within 1 year of age. In addition, Eif4e +/À embryos and adult mice show normal tissue architecture and development (Figures 1B, S1D, and S1E) with no obvious changes in cell size, survival, or proliferation (Figures S1F, S1G, S2A, and S2B). Moreover, Eif4e +/À embryos show equal sensitivity to developmental defects induced by exposure to teratogenic agents, such as alcohol (Table S1 ).
To confirm that eIF4E expression in Eif4e +/À mice is reduced, we analyzed eIF4E mRNA and protein levels. We observed a 50% reduction in eIF4E expression in virtually all cell and tissue types examined in vivo ( Figures 1C, 1D , S2C, and S2D). Next, we asked if there might be compensation for eIF4E loss of function through known translation initiation pathway regulators. However, we found no evidence of compensation in tissues or cells of Eif4e +/À mice at the level of expression or phosphorylation of any other component of the eIF4F initiation complex or of the inhibitor proteins, eIF4E binding protein 1 and 2 (4EBP1 and 4EBP2), which block the interaction of eIF4E with eIF4G (Figure 1E ) (Bah et al., 2015; Haghighat et al., 1995) . In addition, eIF4E activity is directly regulated by phosphorylation at Serine 209 by the Mnk kinases; however, we saw no signs of compensation for reduced eIF4E levels through enhanced phosphorylation ( Figure 1E ) (Waskiewicz et al., 1997 Figure S2 .
translation, an alternative form of translation that is independent of the 5 0 cap structure (Macejak and Sarnow, 1991) . To address this question, we employed a transgenic mouse that stably expresses a bicistronic luciferase reporter for cap-and IRES-mediated translation in all tissues (CMV-HCV-IRES T ) (Bellodi et al., 2010; Hsieh et al., 2010) . By crossing Eif4e +/À mice with CMV-HCV-IRES T reporter mice and assaying Rluc and Fluc expression in primary mouse embryonic fibroblasts (MEFs), we found that Eif4e +/À mice are not impaired in either cap-or IRES-mediated translation. These findings demonstrate that reductions in eIF4E do not induce a switch from capto IRES-dependent translation ( Figure 1H ).
Eif4e
Haploinsufficiency during Cellular Transformation Next, we asked if eIF4E expression levels are critical during stress conditions that impinge on protein synthesis, such as during the early steps downstream of oncogenic signaling (Barna et al., 2008) . Oncogenic signaling increases expression and phosphorylation of eIF4E and leads to hyperphosphorylation and inactivation of the eIF4E inhibitor protein, 4EBP1 ( Figures  2A-2C ) (Aoki et al., 2001; Rajasekhar et al., 2003; Rosenwald et al., 1993) . Modest overexpression of an eIF4E transgene under the control of the ubiquitous b-actin promoter results in the formation of multiple cancer types (Ruggero et al., 2004) , and phosphorylation of eIF4E at Ser209 has been shown to be required for tumorigenesis (Furic et al., 2010) . In addition, overexpression and hyperactivation of eIF4E is a common feature of many human cancers (De Benedetti and Graff, 2004 ). Yet, it remains an outstanding question how changes in the levels of eIF4E expression lead to cellular transformation and whether this is mediated through control of either global or transcriptspecific mRNA translation.
We first tested the ability of specific oncogenic insults, such as Ras and Myc, as well as Ras and E1A, to transform primary Eif4e +/À MEFs under conditions in which eIF4E is genetically reduced by 50%. Notably, Eif4e +/À MEFs show a consistent 50% reduction in eIF4E expression levels even upon oncogenic insult (Figures 2A and 2B ). Similar to steady state, no compensation is observed with respect to eIF4E phosphorylation or other components of the eIF4F initiation complex (Figures 2A-2C ). Additionally, no differences are observed in cell size or expression of the driving oncogenes in Eif4e +/À cells compared to WT (Figures S2H and S2I) . Strikingly, Eif4e +/À MEFs are dramatically resistant to cellular transformation as measured by soft agar colony formation ( Figures 2D and S2J ). In addition, transformation defects can indicate genes with a fold change in translation efficiency (polysomal/total RNA) greater than 1.7-fold; p < 0.05 (see Table S2 ).
(C) Changes in translation efficiency (TE) induced by transformation in WT and Eif4e +/À MEFs. Red points indicate genes whose fold change in TE during transformation is reduced in Eif4e +/À MEFs compared to WT MEFs (>1.7-fold decrease in TE; p < 0.05) (see Table S2 ).
(D) Network-based cluster analysis of genes and associated functional classes whose translation is increased upon transformation in WT MEFs. Pink nodes represent genes whose translation is impaired in transformed Eif4e +/À cells.
See also Figure S3 and Table S2. be ascribed specifically to reductions in the dose of eIF4E as soft agar colony growth is rescued by restoring eIF4E expression levels ( Figures 2D and S2K ). Thereby, eIF4E dose becomes critical under specific cellular stress conditions, such as during cellular transformation.
Profiling the Oncogenic Translation Program
In order to gain insight into the underlying mechanism by which Eif4e +/À cells are resistant to oncogenic transformation, we next asked if the dose of eIF4E is critical for global protein synthesis during this cellular stress. Remarkably, although oncogenic transformation leads to substantial increases in global protein synthesis relative to untransformed cells, transformed Eif4e +/À MEFs showed no defects in global protein synthesis rates as measured by incorporation of 35 S-labeled methionine or by assessing Rluc and FLuc expression in cells isolated from CMV-HCV-IRES T reporter mice (Figures 2E and 2F) . In line with this, reductions in the dose of eIF4E have no impact on the global redistribution of mRNAs from monosomes to actively translating polysomes during cellular transformation ( Figure S2L ). We therefore asked whether the dose of eIF4E is critical in regulating the translation of a specific subset of mRNAs integral to oncogenic transformation. We characterized the impact of oncogenic signaling on the translational landscape of gene expression by undertaking an unbiased translational profiling approach to monitor changes in polyribosomal-associated mRNA and total transcript levels induced by cellular transformation in WT and Eif4e +/À MEFs ( Figure 3A ; Table S2 ). By comparing the relative differences in the ratio of polysomal mRNA isolated from high MW sucrose gradient fractions to total mRNA expression levels (termed translational efficiency), we identified 722 gene products whose translational efficiency (TE) was altered by oncogenic transformation with Ras and Myc in WT MEFs (absolute fold change in TE > 1.7; p < 0.05; Figure 3B ; Table S2 ). Importantly, we found that the translation of a subset of 133 gene products is sensitive to the dose of eIF4E, specifically during oncogenic transformation (fold change in TE > 1.7; p < 0.05; Figures 3C, S3A, and S3B; Table S2 ). In order to better understand how the dose of eIF4E impacts expression of the translational program induced by oncogenic transformation, we performed network-based cluster analysis of interactions for the 722 genes that were either translationally induced ( Figures 3D and S3C ) or repressed by transformation ( Figure S3D ). We found that gene sets translationally regulated by transformation are enriched in protein-protein interactions with several functional clusters emerging from this analysis, including those involved in cell-cycle control, signaling, cellto-cell communication, cell adhesion, and protein homeostasis. Moreover, this analysis highlights how specific subsets of these genes are translated in a manner sensitive to the dose of eIF4E. It is interesting to note that reductions in the dose of eIF4E are also associated with the increased translation of a subset of mRNAs. While the functional relevance of these changes remains to be determined, they could possibly reflect mRNAs that are translated in a cap-independent manner. Thus, employing unbiased genome-wide translational profiling, we identified a translational program comprised of 722 gene products translationally controlled during cellular transformation and demonstrated that eIF4E is critical for the translational activation of a specific subset of this ''oncogenic translation program.'' Since our network data analysis suggested that cellular transformation may promote the translation of distinct classes of mRNAs, we next performed gene set enrichment analysis (GSEA) to identify functional classes of genes whose translation is statistically enriched by cellular transformation and to evaluate their eIF4E dose requirements. This analysis revealed a large and diverse group of functional ontologies whose translation was enhanced by cellular transformation, including classes of genes known to be translationally regulated downstream of oncogenic signaling, such as cell cycle, apoptosis, ribosome biogenesis, and nucleotide biosynthesis (Table S3) (Cunningham et al., 2014; Hsieh et al., 2010 Hsieh et al., , 2012 Stumpf et al., 2013) . In line with our network interactome data, we find that eIF4E levels are limiting for the expression of a subset of functional gene classes that are translationally induced by transformation (Table S3) . For example, a 50% reduction in eIF4E significantly impacts the translation of genes involved in the proteasome, cell signaling, and nucleotide biosynthesis (Figure S4A ; Table S4 ).
Strikingly, this analysis also revealed unexpected coordinate translational upregulation of genes involved in both the production of reactive oxygen species (ROS) and the regulation of ROS levels during cellular transformation. Both oncogenic signaling and deregulated mitochondrial respiration of cancer cells can contribute to ROS generation and oncogenic stress (Irani et al., 1997; Sattler et al., 2000; Vafa et al., 2002; Wallace, 2012) . Importantly, the ability of cancer cells to modulate the dosage and duration of ROS production is vital for their growth and survival. Mitochondrial oxidative phosphorylation, the main source of cellular ROS (Wallace, 2012) , is one of the functional classes most translationally enriched by transformation (Figures 4A and  S4B ; Table S5 ). In addition, we found that transformation enhanced the translation of genes involved in detoxifying and regulating ROS levels, including glutathione metabolism genes (Figures S4B and S4C ; Table S5 ). Remarkably, the dose of eIF4E appears to be critical during cellular transformation for select translation of mRNAs that control intracellular ROS levels, but not for mRNAs associated with oxidative phosphorylation (Table S3) .
In order to better understand the eIF4E requirements in translational control of this distinct class of genes, we next expanded our functional analysis to more broadly examine genes involved in the regulation and response to ROS, and we identified 99 genes translationally induced upon oncogenic transformation (Figures 4B and S4D ; Table S6 ). Strikingly, we observed that a large fraction, 26, of these genes are sensitive to the dose of eIF4E (Figures 4C and S4E ; Table S6 ), including the ferritin heavy chain (Fth1), the catalytic subunit of glutamate-cysteine ligase (Gclc), and lamin B1 (Lmnb1) ( Figures  4D-4F ) (Malhas et al., 2009; Pham et al., 2004; Shi et al., 2000) . Importantly, we found that the translation of genes involved in the regulation and response to ROS was significantly reduced in Eif4e +/À cells only upon cellular transformation ( Figures S4F and S4G) . Moreover, qPCR analysis of polysomal mRNA distribution confirmed that this gene class was indeed translationally enhanced by transformation in an eIF4E-dependent manner, as visualized by a diminished shift of mRNAs into actively translating high MW polysomes in Eif4e +/À cells upon transformation ( Figures S5 and S6) . Thus, this analysis identified groups of functional gene classes whose translation is induced by transformation in an eIF4E-dependent manner, including a class of mRNAs involved in the response to oxidative stress.
A 5
0 UTR Signature of eIF4E-Dependent mRNAs It has been previously proposed that long 5 0 UTRs and complex secondary structures embedded within them, revealed by high GC content and low free energies, render certain transcripts sensitive to eIF4E activity (Pickering and Willis, 2005) . Importantly, 5 0 UTR luciferase reporter assays demonstrate that the 5 0 UTR of eIF4E target mRNAs, such as Fth1, Lmnb1, and Edn1, is sufficient to confer translational sensitivity to eIF4E expression levels ( Figures 5A and 5B) . Surprisingly, however, we see no major differences in 5 0 UTR length, GC content, or free energy in eIF4E translational targets compared to the whole genome ( Figure 5C ). This suggests that additional features of specific 5 0 UTRs may sensitize them to changes in eIF4E expression levels. In order to identify potential cis-acting regulatory elements that may confer sensitivity to the dose of eIF4E during oncogenic transformation, we performed an unbiased Multiple Em for Motif Elicitation (MEME) search for sequence-specific motifs present in the 5 0 UTRs of eIF4E-sensitive mRNAs. This analysis identified a cytosine-rich 15-nucleotide motif that we have termed the cytosine-enriched regulator of translation (CERT) domain (Figure 5D ; Table S7 ).
The CERT domain is present in nearly 70% of eIF4E target mRNAs and is preferentially enriched (81%; p < 0.05) in the subset of eIF4E targets increased by oncogenic transformation, including oxidative stress response genes like Fth1 ( Figure 5D ; Table S7 ). Notably, this motif is located, on average, 143 nt downstream of the 5 0 cap and 146 nt upstream of the AUG start codon and can be present at multiple copies within the 5 0 UTR of target genes. Next, we directly ascertained the possible functional significance of the CERT domain within the context of eIF4E-sensitized mRNAs identified in this study. Mutations of individual motifs in the 5 0 UTR of the eIF4E targets Fth1 and Edn1 are sufficient to restore translational differences conferred by eIF4E levels, and thus the CERT domain has the potential to explain, at least in part, target mRNAs that are sensitized to eIF4E expression levels ( Figure 5E ). Notably, not all eIF4E targets contain a CERT motif; thus, it is likely that other context-dependent features of the 5 0 UTR can confer functionality toward Table S5 ) during cellular transformation (KEGG; FDR < 0.01), (B) enrichment for a broad class of genes involved in the regulation and response to oxidative stress (see Table S6 ) during cellular transformation (FDR < 0.01), and (C) Eif4e
MEFs are defective in a subset of translationally regulated genes involved in the regulation and response to oxidative stress during cellular transformation (see Table S6 eIF4E-selective translation and potentially work in concert with the CERT.
Collectively, these data demonstrate remarkable translational reprogramming of genes involved in control of ROS upon oncogenic transformation that are sensitized to the dose of eIF4E and marked by the presence of the 5 0 UTR cis-acting motif.
eIF4E-Dependent Control of ROS during Oncogenic Transformation and In Vivo Tumorigenesis
Given the unexpected functional role for eIF4E in the expression of genes involved in the control of reactive oxygen species during oncogenic transformation, we next examined the ability of Eif4e +/À cells to regulate and respond to ROS. The ability to recognize and detoxify ROS is critical for the process of oncogenic transformation (DeNicola et al., 2011) . In particular, the accumulation of ROS is associated with the high proliferative capacity and altered mitochondrial respiration of cancer cells and needs to be detoxified in order to maintain tumor growth (Raj et al., 2011; Trachootham et al., 2006) . In line with decreased translation of ROS target genes, fluorescent staining with CM-H2DCFDA reveals that Eif4e +/À cells display elevated levels of intracellular ROS downstream of oncogenic transformation by Ras and Myc ( Figure 6A ). Importantly, we find that transformed Eif4e +/À cells are significantly more sensitive to both the addition of exogenous ROS and treatment with a redox-cycling agent, DMNQ, which induces superoxide formation ( Figures 6B and  S7A ). Indeed, we find that transformed Eif4e +/À cells undergo programmed cell death under anchorage-independent growth conditions known to induce the accumulation of ROS (Schafer et al., 2009) , suggesting that eIF4E is required to maintain accurate levels of ROS compatible with cancer cell survival ( Figure 6C ).
To extend these findings to specific genes that control ROS levels, we examined the roles of Fth1 and Gclc during the process of oncogenic transformation. Fth1 encodes an iron storage protein that possesses intrinsic ferroxidase activity, allowing it to neutralize toxic reactive oxygen species (Pham et al., 2004) . Gclc encodes the catalytic subunit of glutamate-cysteine ligase, the rate-limiting enzyme for the synthesis of glutathione used by glutathione peroxidase to neutralize ROS (Shi et al., 2000) . Importantly, translation of Fth1 and Gclc is significantly enhanced by oncogenic signaling and highly sensitized to eIF4E expression levels ( Figures 4D and 4E) . Strikingly, we find that knockdown of either Fth1 or Gclc is sufficient to inhibit oncogenic transformation, mirroring the resistance to cellular transformation and sensitivity to ROS observed in Eif4e +/À cells ( Figures 6D-6G and S7B-S7H) . Therefore, we asked if the inability to regulate ROS underlies the transformation defect S7I , and S7J). Next, we tested eIF4E dose requirements in the setting of in vivo tumorigenesis driven by endogenous expression of oncogenic KRas. Importantly, the ability to properly respond to and control ROS is critical for lung cancer driven by endogenous expression of oncogenic KRas (DeNicola et al., 2011; Sayin et al., 2014) . Thus, we asked what effect genetically reducing the dose of eIF4E by 50% would have in the KRas LA2 model of lung cancer ( Figure 7A ) (Johnson et al., 2001) . We found that limiting eIF4E levels has a dramatic effect on KRas-driven tumor initiation as revealed by a significant reduction in tumor number by 12 weeks of age in Eif4e +/À mice ( Figure 7B ). Strikingly, this manifests in a more than 2-fold reduction in tumor burden in Eif4e +/À mice at 1 year of age ( Figures 7C and 7D) . Importantly, we found that reductions in tumor burden and number are associated with significant increases in oxidative stress, as measured by the protein oxidation marker dityrosine ( Figure 7E ). Moreover, we demonstrated that expression of eIF4E-dependent ROS target genes, such as Fth1 and Gclc, is significantly reduced in tumors of Eif4e +/À mice ( Figures 7F and S7K (legend continued on next page) if reductions in the dose of eIF4E could confer KRas-driven lung cancers with enhanced sensitivity to pharmacological induction of ROS in vivo. We treated KRas LA2 mice with the small molecule piperlongumine (Raj et al., 2011) , which selectively increases levels of ROS, and we monitored the response of WT and Eif4e +/À tumors by micro X-ray computed tomography. We found that Eif4e haploinsufficiency renders KRas LA2 tumors remarkably susceptible to ROS induction compared to WT tumors, leading to significant reductions in tumor volumes upon treatment that are independent from tumor size ( Figures 7G,  7H , and S7L). To extend our observations to human disease, we asked if reducing the dose of eIF4E could inhibit the oncogenic potential of human KRas-driven lung cancer cells through ROS control. We found that short hairpin RNA (shRNA)-mediated knockdown of EIF4E in H460 and A549 non-small-cell lung cancer (NSCLC) cells causes a potent block in their oncogenic potential as measured by soft agar colony formation ( Figures 7I, S7M, and  S7N) . Furthermore, we demonstrate that this block in tumorigenicity is not only associated with a marked decrease in the expression of eIF4E-dependent ROS target genes but can also be rescued, at least in part, by the addition of the antioxidant NAC ( Figures 7I, S7M, and S7N) . Together, these data reveal that the dose of Eif4e becomes critical during tumorigenesis and delineates an eIF4E-dependent translational program underlying regulation and response to ROS during cellular transformation.
DISCUSSION
Collectively, our data unexpectedly uncover that eIF4E expression levels can be maintained at half of the normal genetic dosage without apparent consequences to normal organismal development and global mRNA translation. This finding is consistent with previous cell-based observations showing that depletion of eIF4E by 80%-90% in rabbit reticulocyte extracts has only a moderate effect on protein synthesis (Rau et al., 1996) . Interestingly, shRNA-mediated knockdown of eIF4E by greater than 90% in the HeLa cancer cell line was also shown to have minimal impacts on global protein synthesis rates; however, this study demonstrated that sustained protein synthesis rates could be explained by compensation for reductions in eIF4E through selective degradation of phospho-4EBP1 (Yanagiya et al., 2012) . It is unclear if this compensation may be a feature specific to cancer cell lines addicted to high global protein synthesis rates. Importantly, we find no evidence for similar alterations in levels or phosphorylation of 4EBPs in primary Eif4e +/À cells and mice. However, we cannot formally exclude the potential for unknown compensatory mechanisms arising from reductions in eIF4E levels. In this regard, it is interesting to note that eIF4E hyperactivation, both through direct overexpression or through deletion of 4EBPs, is also compatible with normal organismal development and does not induce any apparent compensatory feedback mechanisms (Blackshear et al., 1997; Ruggero et al., 2004) . Surprisingly, our data suggest that mammalian systems have evolved surplus levels of eIF4E beyond what is required for normal cellular function. Therefore, it remains an outstanding question what benefit an excess of eIF4E might convey at the organismal level under normal cellular conditions. While it is possible that additional translation-independent eIF4E functions, such as mRNA transport (von der Haar et al., 2004) , could require higher levels of eIF4E, our data suggest that the dose of eIF4E may predominately be required to buffer against specific stress conditions, a function which is in turn co-opted by cancer cells during the oncogene-induced stress response that underlies transformation. Deregulated translation control is a hallmark of human cancers and is critical for tumorigenesis downstream of multiple oncogenic signaling pathways (Barna et al., 2008; Hsieh et al., 2010) . However, the full repertoire of mRNAs translationally altered by oncogenic signaling and the underlying molecular mechanisms that direct their translational control remain poorly understood. Employing unbiased genome-wide profiling, we have uncovered an oncogenic translational program comprised of hundreds of mRNAs and found that a specific subset of transcripts within this group is exquisitely sensitized to the dose of eIF4E. Importantly, we have found that translational changes induced by oncogenic signaling affect many functional gene classes, such as those involved in cell signaling, apoptosis, ribosome biogenesis, the proteasome, nucleotide biosynthesis, oxidative phosphorylation, and the oxidative stress response, which may in concert act to promote tumorigenesis. These data further suggest that translational control of mRNAs comprising multiple cellular functions are likely to underlie the remarkable resistance to transformation in Eif4e +/À cells and mice. In this regard, we have functionally delineated the impact of translation control of at least one of these functional classes, a group of mRNAs involved in the regulation and response to ROS, toward cellular transformation. In particular, we have shown that key eIF4E-dependent ROS targets, such as Fth1 and Gclc, are critically required for cellular transformation and, moreover, have demonstrated that antioxidant suppression of ROS in Eif4e +/À cells rescues to a large extent the cellular transformation capacity of these cells. Future studies will be needed to further validate the role of other eIF4E-dependent functional gene classes during tumorigenesis and elucidate specific conditions in which eIF4E-dependent translation of these mRNAs becomes important.
Oxidative stress is one of the defining stress phenotypes encountered during tumorigenesis and cancer cells have been shown to generate more ROS than normal cells (Szatrowski and Nathan, 1991) . In this regard, it has been historically thought that ROS plays a distinctly pro-tumorigenic role. Recent studies have also shown that physiological expression of (legend continued on next page) oncogenes may drive down intracellular ROS levels, suggesting that complex regulation of ROS levels may occur during different stages of in vivo tumorigenesis, as well as downstream of progressive genomic aberrations, such as oncogene amplification. Thereby, our understanding of the key molecular mechanisms responsible for intricately maintaining ROS levels compatible with tumor cell survival is incomplete. Here, we have found that genes regulating ROS are under exquisite translational regulation during oncogenic transformation and are sensitized to eIF4E dose, revealing an unexpected posttranscriptional circuitry regulating ROS levels. For example, Fth1, an iron-storage protein that protects against the formation of hydroxyl radicals, and Gclc, the rate-limiting enzyme for the synthesis of glutathione used to neutralize ROS, are translationally induced by cellular transformation in an eIF4E-dependent manner. Importantly, we have shown that reductions in eIF4E dose lead to significant increases in intracellular ROS downstream of ectopic oncogene expression, sensitizing tumor cells to ROS-induced apoptosis and blocking cellular transformation.
In addition, we have demonstrated that eIF4E is required for proper expression of the ROS response and control of intratumoral oxidative stress underlying in vivo lung tumorigenesis driven by endogenous expression of KRas. Thereby, our data suggest that the regulation of ROS levels through eIF4E-mediated translational control may provide a molecular rheostat that fine-tunes the levels of oxidative species that are selectively required to maintain cancer cell survival. Precisely how distinct subsets of mRNAs become sensitized to eIF4E dose during oncogenic transformation remains an important area of investigation. Classically, long, structured 5 0 UTRs with high GC content and low free energy have been thought to be the only features that confer sensitivity to eIF4E dose. Interestingly, these 5 0 UTR features were not altered in the subset of eIF4E-dependent genes translationally activated by oncogenic transformation. Although we cannot exclude a possible role for distinct subregions of secondary structures within the 5 0 UTRs of eIF4E sensitive genes, our data suggest that alternative modes of translational control may also be important. Recently, there has been an emerging appreciation for the role of shorter, sequence-specific elements embedded within the 5 0 UTR in directing mRNA translation (Hsieh et al., 2012; Thoreen et al., 2012; Wolfe et al., 2014; Xue et al., 2015) . Along these lines, we have found that the majority of eIF4E-dependent mRNAs induced by transformation are marked by the presence of a sequence-specific CERT motif within their 5 0 UTRs, suggesting that this motif may have broader impacts toward eIF4E-dependent translation. Indeed, within the context of target mRNAs, such as Fth1 and Edn1, the CERT motif is required to confer eIF4E sensitivity. However, it remains an outstanding question how the CERT domain acts mechanistically to couple the dose of eIF4E to translational control of specific mRNAs. It is possible, for example, that this motif serves as a docking site for RNA binding proteins that interact either directly or indirectly with eIF4E, potentially to stabilize eIF4E cap binding or promote eIF4F activity. Future studies will be required to address the biochemical mechanisms by which eIF4E interfaces with the CERT motif and how other context-dependent features of the 5 0 UTR influence CERT activity.
Collectively, our data surprisingly show that the long-held dogma that the dose of eIF4E is critically required for translating the mammalian genome needs to be revisited. Maintaining the dose of eIF4E at 50% of the normal level does not appear to be detrimental for normal mammalian development or, even more strikingly, for global protein synthesis control. Our findings further point to the possibility that cancer cells have specifically usurped excess eIF4E levels to promote their growth and survival. The fact that reducing eIF4E expression is not detrimental for normal mammalian physiology reveals a potent therapeutic window for targeting the eIF4E-dependent oncogenic translational program, which may be greatly enhanced in combination with drugs that exploit the sensitivity of cancer cells to ROS.
EXPERIMENTAL PROCEDURES
Complete experimental procedures, including details for protein, RNA, cellular, metabolic, in vivo tumorigenesis, and statistical analysis, can be found in the Supplemental Experimental Procedures.
Mice
Eif4e genetic loss-of-function mice were generated using embryonic stem cells from BayGenomics (line RRO036) and validated for gene-trap insertion by PCR and Southern blot analysis. Eif4e +/À and CMV-HCV-IRES T mice were maintained on a C57BL/6J background. F1 littermates from crosses of Eif4e +/À mice and KRas LA2 mice on an FVB/n background were used for in vivo tumorigenesis experiments. Mice were maintained under specific pathogenfree conditions, and all experiments were performed in compliance with guidelines approved by the Institutional Animal Care and Use Committee of UCSF.
Polysome Fractionation and Isolation of Polysome-Associated RNA for Microarray Primary MEFs, transformed MEFs, and lipopolysaccharide-stimulated B cells were treated with 100 mg/ml cyclohexamide (Sigma) on ice in PBS for 10 min. Cells were pelleted and lysed in 10 mM Tris-HCl (pH 8), 140 mM NaCl, 1.5 mM MgCl 2 , 0.25% NP-40, 0.1% Triton X-100, 50 mM DTT, 150 mg/ml cyclohexamide, and 640 U/ml Rnasin for 30 min. Lysates were cleared, separated on a 10%-50% sucrose gradient by ultracentrifugation, and fractionated using an ISCO gradient fractionation system. For polysome microarrays, RNA was isolated from high MW polysome fractions (fractions 10-13) of three sets of independently isolated primary and matched-transformed WT and Eif4e
MEFs.
Analysis of Microarray Dataset
Affymetrix Mouse Gene 1.0 ST array data were preprocessed by RMA using the aroma.affymetrix R package. Polysomal and total RNA datasets were quantile normalized separately. The difference in log2 intensity between matched polysomal RNA and total RNA was taken to quantify translational efficiency (TE).
(I) Soft agar colony formation potential in the H460 human NSCLC line is decreased upon shRNA-mediated KD of EIF4E and can be rescued by addition of 0.5 mM of the antioxidant NAC (average WT control colony number = 139). Asterisks indicate a statistically significant change (*p < 0.05; **p < 0.01). All values represent the mean + SEM, except for (I), which represent mean + SD. See also Figure S7 .
Gene Set Enrichment Analysis
Gene set enrichment analysis (GSEA) was performed using v.2.0.12 of the GSEA desktop application. Log2 values of translational efficiency (TE) were input into GSEA and analyzed for enrichment in Kyoto Encyclopedia of Genes and Genomes and Gene Ontology Biological Process gene set collections.
Motif Analysis
Multiple Em for Motif Elicitation (MEME) was performed using v.4.9.1 of the MEME browser application. The training set used to identify the CERT (Table  S7 ) was compiled from the longest known 5 0 UTR for RefSeq-annotated mRNAs called from the UCSC Genome Browser. Gene sets were evaluated for the presence of the consensus CERT motif using Find Individual Motif Occurrences (FIMO).
ACCESSION NUMBERS
The accession number for the polysome microarray profiling reported in this paper is GEO: GSE68238. 
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